共 50 条
- [1] Immunomodulatory effects of treatment with a "shared epitope" peptide in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S132 - S132
- [2] Antibodies against cyclic citrullinated peptide (CCP) and shared epitope predict rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S678 - S679
- [3] Meta-analysis of the shared epitope and severity of rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S102 - S102
- [4] Association of the HLA-DRB1 shared epitope with mortality in rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S381 - S381
- [6] Clinical Implications of Shared Epitope and Anti-citrullinated Peptide Antibody in Patients With Rheumatoid Arthritis [J]. JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (03): : 171 - 180
- [7] The shared epitope hypothesis in rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1275 - 1283
- [10] Increased frequency of antifilaggrin antibody in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S312 - S312